There is described a method of treatment of certain psychiatric conditions which method comprises administration of a compound of the formula I, ##STR1## or a therapeutically acceptacle salt, ester or amide thereof, (as active ingredient), to a patient having such a condition.
This application is a continuation-in-part of our copending application Ser. No. 717,875, filed Aug. 26, 1976, now U.S. Pat. No. 4,067,992, issued Jan. 10, 1978.
Priority Data
Sep 15, 1976 [GB] 38101/76 Jun 25, 1977 [GB] 26732/77
The invention relates to a process for the solubilization in a non-ionic surface-action agent of from between about 0.001 mg and about 1 mg of forskolin, to the pharmaceutical compositions based on such solubilized forskolin and to the use of these in the treatment of various diseases and disorders and maladies in mammals, including humans. Forskolin is 7-beta-acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-o ne.
The invention relates to a process for the solubilzation of forskolin, to the pharmaceutical compositions based on such solubilized forskolin and to the use of these in the treatment of various diseases and disorders and maladies in mammals, including human. Forskolin is 7-beta-acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-o ne.
